26
|
Royer-Morrot MJ, Zhiri A, Paille F, Royer RJ. Plasma thiamine concentrations after intramuscular and oral multiple dosage regimens in healthy men. Eur J Clin Pharmacol 1992; 42:219-22. [PMID: 1618256 DOI: 10.1007/bf00278489] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
A novel liquid chromatographic method for the determination of thiamine in plasma has been developed and has been used to study plasma thiamine concentrations after multiple dosage regimens for 11 days. The method involves purification, concentration and analytical separation of thiochrome on-line, using a switching column system. Ten healthy men were given 500 mg thiamine i.m. once a day (Group 1) and ten were given 250 mg p.o. every 12 h (Group 2). The times to reach steady state (7 and 5.6 days for Groups 1 and 2, respectively) were not different (P greater than 0.05). The mean elimination half-life was 1.8 days. The mean minimum steady-state concentration after the oral regimen (23 micrograms.l-1) was 78% of that after the intramuscular regime (29 micrograms.l-1).
Collapse
|
27
|
Royer-Morrot MJ, Gérard A, Zhiri A, Schooneman F, Dureux JB, Royer RJ. Effect of plasma exchange on flumequine pharmacokinetics: comparison with control kinetics. Ther Drug Monit 1991; 13:296-303. [PMID: 1780960 DOI: 10.1097/00007691-199107000-00003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The effect of plasma exchange (PE) on the pharmacokinetics of flumequine (Apurone) was studied in eight patients receiving a single oral dose of 800 mg. The maximum concentration (38 micrograms/ml) and time to maximum concentration (2.6 h) values were not significantly altered by PE beginning 3 h after administration of flumequine. There was no change in the terminal elimination half-lives (6.6 h), in the steady-state volume of distribution (29 L), or in the apparent plasma clearance (2.5 L/h). By contrast, PE decreased the mean residence time by 30% (14.3 +/- 4.1 h without PE; 9.88 +/- 1.36 h with PE; p less than 0.05). The amount of flumequine extracted by PE (72 mg) was proportional to the plasma concentration at the beginning of the exchange. The elimination half-life during PE (3.15 +/- 1.23 h) decreased by 40%. Renal clearance (0.3 L/h) was not affected. PE only partially modifies the pharmacokinetics of flumequine administered in a single oral dose before PE.
Collapse
|
28
|
Royer RJ, Benichou C. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group]. Therapie 1991; 46:173-8. [PMID: 1792648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Under the auspices of the Council for International Organizations of Medical Sciences, a working group composed of representatives of seven multinational pharmaceutical manufacturers and six regulatory authorities developed and implemented a standardized method for reporting post-approval adverse drug reactions (ADR). The method is based on a set of uniform definitions and procedures and a single reporting form, and has been demonstrated to be feasible and effective. Regulators and manufacturers, in establishing requirements and systems for reporting of adverse drug reactions, should consider adopting this method.
Collapse
|
29
|
Royer RJ, Vidrequin A, Trechot P, Boissel P, Netter P. [Cost evaluation of a side-effect of a drug]. Presse Med 1990; 19:1240. [PMID: 2142776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
|
30
|
Abstract
The French system of drug surveillance (pharmacovigilance) is a combination of mandatory reporting and intensive hospital surveillance. The Regional Centres are decentralised but coordinated through a national network. An algorithm index is used to assess the relationship between drugs and adverse effects. The adverse reactions alert system is produced by the compilation and analysis of the cases entered in a data bank (8062 in 1988) and by the analysis of queries from general practitioners (20,000 in 1988). The duties of the centres are also to provide information, analyse data and to improve the safe use of drugs.
Collapse
|
31
|
Caillier I, Bannwarth B, Monot C, Lapicque F, Netter P, Gaucher A, Royer RJ. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY, AND TOXICOLOGY 1990; 28:7-13. [PMID: 2303312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Protein binding of sodium salicylate in synovial fluid and in serum from 23 inpatients with rheumatic diseases were studied, ex vivo, by equilibrium dialysis. Scatchard model with two classes of sites was used as a mathematical tool. At therapeutic concentrations, protein binding of sodium salicylate was significantly higher in serum than in synovial fluid. The ratio of areas under the curves for bound concentrations for synovial fluid to that for serum was 0.867. This difference was attributed to the hypoalbuminemia observed in the synovial fluid; for a given molar ratio of drug to albumin, or in other words, for the same amount of available drug per mole of albumin. The number of sites occupied was the same in the two biological media.
Collapse
|
32
|
Trechot PF, Royer RJ, Gaire M, Gaspard MC, Netter P. [A 30-month study of the calls to the Regional Drug Monitoring Center in Lorraine (Nancy)]. Therapie 1990; 45:43-6. [PMID: 2343435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
For over a period of 30 months, all the questions to the French "Centre de Pharmacovigilance" of Nancy Lorraine have been analysed. The University Hospital of Nancy is by for the main caller (65%) and the suspicion of adverse drug reaction represents 61% of all the questions. Gastrointestinal and hepatic disorders, cardiovascular drugs arouse the greatest number of questions. Comparison with results previously published by some French Pharmacovigilance Centres points out some regional particularities.
Collapse
|
33
|
Lapicque F, Netter P, Bannwarth B, Trechot P, Gillet P, Lambert H, Royer RJ. Identification and simultaneous determination of non-steroidal anti-inflammatory drugs using high-performance liquid chromatography. JOURNAL OF CHROMATOGRAPHY 1989; 496:301-20. [PMID: 2613835 DOI: 10.1016/s0378-4347(00)82579-7] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
An isocratic high-performance liquid chromatographic procedure is presented for the screening of plasma samples for the presence of sixteen non-steroidal anti-inflammatory drugs. Detection was achieved simultaneously at two wavelengths (254 and 370 nm) and the purity of the eluted peaks was tested using absorbance ratios at the two wavelengths; identification could thus be effective without interferences from substances of other pharmacological classes. The drugs were extracted simultaneously with diethyl ether after acidification and separated from each other on an octadecyl reversed-phase column using only one eluent, acetonitrile-0.3% acetic acid-tetrahydrofuran (36:63.1:0.9, v/v). The recovery, precision and reproducibility of the method were satisfactory as it allowed the determination of the drugs from infra- to supratherapeutic concentrations.
Collapse
|
34
|
Marie PY, Zannad F, Parisot M, Royer RJ. Role of ancillary properties of beta-adrenoceptor antagonists in protecting the heart from anoxia. Eur J Pharmacol 1989; 163:337-43. [PMID: 2566504 DOI: 10.1016/0014-2999(89)90203-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The mechanism of the cardioprotective action of beta-blocking drugs against anoxia or ischemia is still not clear. We used beta-blockers (5 x 10(-7) M) of various pharmacodynamic profiles in a model of isolated, perfused working guinea pig heart subjected to 20 min of anoxia to study this. The cardioprotective effects were evaluated by measuring the recovery of the flow indices after 15 min of reoxygenation. There was a significant cardioprotective action (as measured by the effect on stroke volume recovery and on recovery of other flow and work indices) of the beta-blocking properties (nadolol, P less than 0.05), of the membrane-stabilizing property [+)-propranolol, P less than 0.05) and of a combination of these two properties with (+/-)-propranolol, which had a significantly greater effect than nadolol (P less than 0.05). The addition of weak (acebutolol) or strong (pindolol) intrinsic partial agonist activity had no clear unfavourable effect, as the degree of cardioprotection was comparable with that obtained with (+/-)-propranolol. The stroke volume recovery (percent recovery after anoxia) in the control hearts was 42.57 +/- 12.75 compared to 54.84 +/- 6.94 in hearts pretreated with nadolol, 62.99 +/- 11.41 with (+)-propranolol, 71.02 +/- 11.36 with (+/-)-propranolol, 72.63 +/- 13.08 with acebutolol and 68.01 +/- 15.42 with pindolol. In vitro heart protection from anoxia with beta-blockers would appear to be related to beta-blocking activity and/or membrane stabilizing property but not a function of partial agonist activity. These ancillary properties of beta-blockers should thus be taken into account in studies on cardioprotection.
Collapse
|
35
|
Royer RJ, Royer-Morrot MJ, Paille F, Barrucand D, Schmitt J, Defrance R, Salvadori C. Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis. Clin Pharmacokinet 1989; 16:186-91. [PMID: 2721088 DOI: 10.2165/00003088-198916030-00005] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The effect of chronic alcoholism (with or without associated moderate cirrhosis) on the disposition of the antidepressant tianeptine, which is devoid of substantial first-pass metabolism, was examined in 21 patients and 11 age-matched controls. Pharmacokinetic parameters for tianeptine and its C5 acid analogue metabolite (MC5 metabolite) were estimated by non-compartmental analysis. The area under the curve (AUC) for tianeptine, following a 12.5mg single oral dose, was decreased by 31% in chronic alcoholics and increased by only 14% in cirrhotics, compared to controls. These changes did not attain statistical significance. The trend of changes in the AUC for the MC5 metabolite was similar to that observed for the parent drug. No statistical difference was found in the terminal half-life for both tianeptine and its MC5 metabolite between patients and controls. On the basis of this study, it appears unnecessary to modify the proposed dosage regimen used in clinical trials (tianeptine sodium salt 12.5mg 3 times daily) in chronic alcoholics with or without associated moderate cirrhosis.
Collapse
|
36
|
Bannwarth B, Netter P, Pourel J, Royer RJ, Gaucher A. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomed Pharmacother 1989; 43:121-6. [PMID: 2660917 DOI: 10.1016/0753-3322(89)90140-6] [Citation(s) in RCA: 59] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
The pharmacokinetics of nonsteroidal anti-inflammatory drugs (NSAIDs) in the cerebrospinal fluid (CSF) is of clinical interest as it may be related to some of their properties and side-effects. Two types of NSAIDs can be described with respect to their concentration and time course in CSF: in the first type, the transfer across the blood-brain barrier seems to be controlled by simple physico-chemical factors. These drugs (oxyphenbutazone, indomethacin, ketoprofen) are characterized by a high lipophilicity. At steady state, their free plasma concentrations correspond to their CSF concentrations. The second group consists of more hydrophilic compounds (salicylates); there is no correlation between plasma concentrations and CSF concentration. Further investigation needs to be carried out on CNS side-effects and the antialgesic activity of salicylates in relation on their CSF distribution.
Collapse
|
37
|
Netter P, Bannwarth B, Faure G, Tréchot P, Royer RJ. Adverse effects of D-penicillamine. A cooperative study by the French Regional Drug Surveillance Centers. J Rheumatol 1988; 15:1730-2. [PMID: 3070030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
38
|
Bannwarth B, Netter P, Manciaux MA, Royer RJ. [Pharmacokinetics of non-steroidal anti-inflammatory agents in the elderly]. Therapie 1988; 43:447-50. [PMID: 3067421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
39
|
Netter P, Paille F, Trechot P, Bannwarth B, Royer RJ. [Drug-induced esophageal complications. A cooperative study of hospital drug monitoring centers in France]. Therapie 1988; 43:475-9. [PMID: 3227513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
40
|
Paille F, Boccaccini A, de Korwin JD, Schmidt C, Laprevote MC, Schmitt J, Royer RJ. [Thrombopenia under low molecular weight heparin after treatment with pentosan polyphosphate]. Therapie 1988; 43:322-3. [PMID: 2460963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
41
|
Bannwarth B, Lapicque F, Netter P, Monot C, Tamisier JN, Thomas P, Royer RJ. The effect of food on the systemic availability of ketoprofen. Eur J Clin Pharmacol 1988; 33:643-5. [PMID: 3366169 DOI: 10.1007/bf00542503] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
We have studied the pharmacokinetics of ketoprofen, a non-steroidal anti-inflammatory drug, in 12 patients after a single 100 mg oral dose both in fasting conditions and with a meal. Food significantly affected the peak plasma concentration of ketoprofen and decreased its absorption rate. However, the extent of absorption of ketoprofen, as reflected by the area under the plasma concentration time curve, appeared to be unchanged in the presence of food.
Collapse
|
42
|
Netter P, Bannwarth B, Lapicque F, Harrewyn JM, Frydman A, Tamisier JN, Gaucher A, Royer RJ. Total and free ketoprofen in serum and synovial fluid after intramuscular injection. Clin Pharmacol Ther 1987; 42:555-61. [PMID: 3677544 DOI: 10.1038/clpt.1987.196] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Free and total ketoprofen levels in serum and synovial fluid were determined in 37 patients after a single intramuscular injection of ketoprofen, 100 mg. Free drug was separated by equilibrium dialysis. Ketoprofen was assayed by HPLC. Ketoprofen penetrated into the joints rapidly and significant concentrations were found at 15 minutes. The equilibrium time was about 3 1/2 hours. The AUC for total ketoprofen was greater in serum than in synovial fluid. On the other hand, the free fraction AUC in the serum and synovial fluid were quite similar. The mean residence time in the joint was about three times that in the systemic circulation. Ketoprofen was strongly bound to proteins and the percentage of free ketoprofen was not significantly different between serum and synovial fluid. These results provide a possible explanation for duration of the therapeutic effect of ketoprofen despite the short elimination half-life from the serum.
Collapse
|
43
|
Netter P, Bannwarth B, Royer RJ. [Which drug surveillance for a non-steroidal anti-inflammatory agent?]. Presse Med 1987; 16:1503-4. [PMID: 2958814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
|
44
|
Zannad F, Royer-Morrot MJ, Zakari I, Sadoul N, Royer RJ. Conversion from intravenous to oral slow-release disopyramide in acute myocardial infarction. Fundam Clin Pharmacol 1987; 1:219-24. [PMID: 3428841 DOI: 10.1111/j.1472-8206.1987.tb00560.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Twelve patients with acute myocardial infarction were given 1.5 mg/kg/5 min bolus +0.4 mg/kg/hr 6 hr IV infusion of disopyramide followed by 250 mg twice daily of a slow-release oral formulation of this drug. Plasma concentrations of total disopyramide rapidly reached steady-state within the therapeutic margins. The plasma steady-state concentrations of the major metabolite mono-N-dealkyl-disopyramide (MND) showed large intra-individual variations. There was no correlation between plasma levels of either disopyramide or MND and the occurrence of anticholinergic side effects. The drug had no significant effect on mean blood pressure, heart rate, or ECG intervals. This therapeutic regimen, including conversion from the IV form to oral slow-release tablets, could be recommended in myocardial infarction.
Collapse
|
45
|
Bannwarth B, Netter P, Gaucher A, Royer-Morrot MJ, Royer RJ. [Diffusion of salicylates through the hemato-encephalic barrier in adults]. Therapie 1986; 41:409-11. [PMID: 3810534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
46
|
Bannwarth B, Netter P, Gaucher A, Royer RJ. Delayed appearance of salicylate in cerebrospinal fluid. J Rheumatol 1986; 13:993-4. [PMID: 3820214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
47
|
Lapicque F, Netter P, Monot C, Bannwarth B, Maknassi MS, Royer RJ. [Determination of protein binding of drugs using equilibrium dialysis. Influence of volume displacement caused by osmotic pressure]. JOURNAL DE PHARMACOLOGIE 1986; 17:295-300. [PMID: 3795973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
By the determination of the free concentration of a drug using the equilibrium dialysis method, a volume shift could be observed, inducing a dilution of the protein medium. The value of this volume shift varies with the plasmatic sample and could produce a misdetermination of the free fraction which could be important, essentially for the drugs strongly bound to proteins.
Collapse
|
48
|
Zannad F, Royer RJ, Gilgenkrantz JM. [Clinical evaluation of drugs in chronic cardiac failure]. Presse Med 1986; 15:574-8. [PMID: 2939408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
As the acute complications of cardiovascular diseases are better controlled, the number of patients with chronic heart failure will no doubt increase, together with the need for new treatments of this condition. The effectiveness of these new drugs on the heart function and on the patient's functional status, quality of life and survival must be assessed by very strict evaluation methods. Evaluating the cardiac function requires haemodynamic investigations by proven techniques. Even when taken globally, the haemodynamic values do not always provide information on the patient's clinical and functional status which must therefore be assessed separately, using specific methods. The exercise load, duration and oxygen peripheral consumption measured by established techniques are, in fact, the variables best correlated with the patient's functional status. The effects of drugs must be evaluated at rest and during exercise, but also in short and long term, with a systematic search for tachyphylaxis. Improvements in much less than quality of life much greater than and tolerance of treatment can be evaluated by appropriate questionnaires filled in by the patients. Assessing the effect of any treatment on survival of cardiac patients is always difficult. It requires epidemiological studies which are invariably delicate and costly but cannot be avoided for such an important matter.
Collapse
|
49
|
Dangoumau J, Lagier G, Royer RJ. A drug information-ADR collection network: the French system. DRUG INFORMATION JOURNAL 1985; 20:337-46. [PMID: 10317774 DOI: 10.1177/009286158602000315] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
50
|
Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer RJ. Adverse drug reaction monitoring: doing it the French way. Lancet 1985; 2:1056-8. [PMID: 2865527 DOI: 10.1016/s0140-6736(85)90918-3] [Citation(s) in RCA: 156] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|